Utilising survey data to inform public policy: Comparison of the cost-effectiveness of treatment of ten mental disorders
Top Cited Papers
- 1 June 2004
- journal article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 184 (6) , 526-533
- https://doi.org/10.1192/bjp.184.6.526
Abstract
Background Mental health survey data are now being used proactively to decide how the burden of disease might best be reduced. Aims To study the cost-effectiveness of current and optimal treatments for mental disorders and the proportion of burden avertable by each. Method Data for three affective, four anxiety and two alcohol use disorders and for schizophrenia were compared in terms of cost, burden averted and efficiency of current and optimal treatment. We then calculated the burden unavertable given current knowledge. The unit of health gain was a reduction in the years lived with disability (YLDs). Results Summing across all disorders, current treatment averted 13% of the burden, at an average cost of AUS$30 000 per YLD gained. Optimal treatment at current coverage could avert 20% of the burden, at an average cost of AUS$18 000 per YLD gained. Optimal treatment at optimal coverage could avert 28% of the burden, at AUS$16 000 per YLD gained. Sixty per cent of the burden of mental disorders was deemed to be unavertable. Conclusions The efficiency of treatment varied more than tenfold across disorders. Although coverage of some of the more efficient treatments should be extended, other factors justify continued use of less-efficient treatments for some disorders.Keywords
This publication has 31 references indexed in Scilit:
- Reducing the burden of affective disorders: is evidence-based health care affordable?Journal of Affective Disorders, 2003
- Invited commentary on: Cost-effectiveness of current and optimal treatment for schizophreniaThe British Journal of Psychiatry, 2003
- How much of the burden of schizophrenia is alleviated by treatment?The British Journal of Psychiatry, 2003
- Summary of Guideline for the Treatment of DepressionAustralasian Psychiatry, 2003
- Summary of Guideline for the Treatment of Panic Disorder and AgoraphobiaAustralasian Psychiatry, 2003
- Prevalence, comorbidity, disability and service utilisationThe British Journal of Psychiatry, 2001
- The World Health Organization International Consorthm in Psychiatric Epidemiology (ICPE): initial work and future directions ‐ the NAPE Lecture 1998aActa Psychiatrica Scandinavica, 1999
- The ethics of allocation of scarce health care resources: a view from the centre.Journal of Medical Ethics, 1994
- Cost Utility of Maintenance Treatment of Recurrent Depression with Sertraline Versus Episodic Treatment with DothiepinPharmacoEconomics, 1994